Knowlton
TL3 Regular · Szeged, HU
Clinician. Posts general information only, and says so every time.
Joined 27 October 2024 · last posted 2d · groups: clinicians
144 posts, newest first. Showing up to 150.
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #61 · Pharmacology › Pharmacokinetics · 26 Jul 2026 · 11 likes Coming back to post #57, because the follow-up matters more than the original answer. Steady state is approached in roughly four to five half-lives. For a compound with…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #69 · Practice › Interactions · 25 Jul 2026 · 2 likes Right, and stated more narrowly than I would have dared to state it.
-
Journal club: what we got wrong in an earlier session Replied, post #118 · Evidence › Journal club · 25 Jul 2026 · 31 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Coming back to: Telehealth prescribing models in the US Replied, post #27 · Regional › North America · 24 Jul 2026 · 10 likes What I would want before treating Telehealth prescribing models as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
-
What a certificate commits its issuer to Replied, post #94 · Analytics › COA interpretation · 24 Jul 2026 · 5 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #40 · Practice › Dosing & titration · 22 Jul 2026 · 29 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #138 · Sourcing › Logistics · 18 Jul 2026 · 7 likes Posting my Regional warehouse stock versus direct numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone…
-
NHS criteria and how they are applied in practice Replied, post #33 · Regional › UK & Ireland · 17 Jul 2026 · 18 likes Small methodological point on NHS criteria: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Here for the analytics and not much else Replied, post #28 · Lounge › Introductions · 13 Jul 2026 · 6 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
Insurance and replacement policies, compared Replied, post #78 · Sourcing › Logistics · 10 Jul 2026 · 22 likes Narrowing post #77, because the general version has more than one answer. Insurance and carrier liability: most parcel carriers limit liability. Understanding the…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #87 · Evidence › Journal club · 7 Jul 2026 · 0 likes On post #86 — agreed on the reasoning, with one qualification. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #68 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 15 likes On post #66 — agreed on the reasoning, with one qualification. Area percent is a proportion of absorbance, not a proportion of mass. Two species with different…
-
Documenting a supplier's response to a discrepancy Replied, post #28 · Sourcing › Vendor reports · 2 Jul 2026 · 0 likes Answering the question post #26 raises rather than the one it answers. If the supplier was asked about a discrepancy, include what they said verbatim rather than…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #30 · Start Here › Welcome · 30 Jun 2026 · 0 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #21 · Evidence › Meta-analyses · 30 Jun 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
GLP-1 receptor distribution: central and peripheral Replied, post #80 · Pharmacology › Receptor biology · 30 Jun 2026 · 0 likes Taking post #77 at face value and following it one step further. Long-term receptor changes: very little is known about what happens to receptor expression, signalling,…
-
Pooling trials with different estimands Replied, post #58 · Evidence › Meta-analyses · 29 Jun 2026 · 0 likes A meta-analysis of four small trials is not stronger evidence than one adequately powered trial, whatever the summary statistic looks like.
-
Historical amylin analogues and what happened to them Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 29 Jun 2026 · 25 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Second pass at: Programming during a large energy deficit Replied, post #43 · Nutrition & Training › Resistance training · 24 Jun 2026 · 2 likes Reading back through the Programming during a large energy threads from last year, the same three questions come up every time and only one of them has ever been…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #17 · Sourcing › Vendor reports · 22 Jun 2026 · 28 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial. That is what…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #40 · Compounds › Secretagogues & GH axis · 18 Jun 2026 · 18 likes Agreed on all of that, and I have nothing to add to it.
-
Pages past their review date, listed — does this still hold? Replied, post #10 · Meta › Wiki maintenance · 12 Jun 2026 · 30 likes Where I part company with post #8, and it is a narrow parting. That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
-
Prescription portability between countries Replied, post #62 · Access › International · 12 Jun 2026 · 20 likes Prescription portability between countries sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #21 · Practice › Administration · 10 Jun 2026 · 4 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Micronutrient adequacy at low total intake Replied, post #31 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 0 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population.
-
Racemisation and why it is invisible to a mass measurement Replied, post #9 · Analytics › Impurities & related substances · 8 Jun 2026 · 2 likes This follows post #8 rather than contradicting it. One more thing on racemisation that took me far too long to see: the two figures people quote are not measuring the…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #90 · Practice › Storage & stability · 8 Jun 2026 · 2 likes One caution on reconstituted: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #90 · Outcomes › Body composition · 6 Jun 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #72 · Sourcing › Red flags · 5 Jun 2026 · 10 likes Post #70 put the caveat in the right place and I want to underline it. I changed my mind about certificate whose chromatogram axes after someone here asked me for the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #82 · Data & Tools › Calculators · 4 Jun 2026 · 4 likes Post #81 and I disagree about the size of the effect, not about the direction. Careful with the language on titration planner refuses. "Not detected" and "not present"…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #14 · Practice › Administration · 31 May 2026 · 10 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Second-hand on Angle of injection, so weight it accordingly — someone whose method I…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #37 · Analytics › Home & field testing · 30 May 2026 · 32 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #8 · Pharmacology › Pharmacokinetics · 30 May 2026 · 6 likes Post #4 put the caveat in the right place and I want to underline it. Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #32 · Analytics › Home & field testing · 28 May 2026 · 3 likes Adding the measurement that post #29 says would settle it. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #35 · Analytics › Home & field testing · 25 May 2026 · 3 likes This follows post #34 rather than contradicting it. Reading this Reflectance and photometric devices thread as someone who came in with a fixed view: the third and…
-
Why the timeline is on the right and not the left — what changed since Replied, post #39 · Meta › Site feedback · 19 May 2026 · 0 likes Picking up post #36: that is the part I would want checked first. Suggestion rather than complaint: the vendor pages carry a review date, and topics do not. A topic…
-
Blind submission and why it changes minds — the long version Replied, post #76 · Sourcing › Independent verification · 15 May 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #2 · Clinical › Special populations · 7 May 2026 · 11 likes One caution on bariatric surgery history: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
-
Blind submission and why it changes minds — the long version Replied, post #61 · Sourcing › Independent verification · 7 May 2026 · 4 likes Post #58 is right about the mechanism and I think understates the practical bit. Two claims get bundled together under Blind submission and they need separating. The…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #97 · Practice › Interactions · 1 May 2026 · 0 likes Common supplements: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #6 · Compounds › Semaglutide · 30 Apr 2026 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #4 · Analytics › Home & field testing · 25 Apr 2026 · 27 likes The opening post describes the usual case. This is about the unusual one. Weighing vials against declared fill is the most underrated home check available. It needs a…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #104 · Practice › Reconstitution · 24 Apr 2026 · 31 likes I read post #102 twice before replying, because I had assumed the opposite. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Bioimpedance and hydration: why the number moves Replied, post #32 · Outcomes › Body composition · 17 Apr 2026 · 5 likes Where I part company with post #28, and it is a narrow parting. The version of bioimpedance and hydration that I was taught turned out to be a teaching simplification.…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #16 · Practice › Administration · 17 Apr 2026 · 0 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Moderation log format change Replied, post #45 · Meta › Announcements · 17 Apr 2026 · 10 likes Taking post #44 at face value and following it one step further. The honest answer on moderation log format change is that it depends, and the useful part is the list…
-
Batch numbers that do not match the vial label Replied, post #6 · marked as the solution · Sourcing › Red flags · 16 Apr 2026 · 12 likes Adding the measurement that post #3 says would settle it. What would change my mind on batch numbers is a second dataset collected by someone with no stake in the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #30 · Evidence › Preprints · 14 Apr 2026 · 16 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #21 · Data & Tools › Calculators · 3 Apr 2026 · 1 like The reconstitution calculation is total mass divided by total volume for concentration, then dose divided by concentration for volume, then volume times one hundred for…
-
Journal club: is percentage weight change the right endpoint? Replied, post #22 · Evidence › Journal club · 29 Mar 2026 · 29 likes Post #21 is the version of this I will quote in future. One addition. The baseline characteristics table is the single most useful page for the questions that get asked…
-
CJC-1295 with and without DAC: what the modification does Replied, post #17 · Compounds › Secretagogues & GH axis · 21 Mar 2026 · 10 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #153 · Sourcing › Independent verification · 8 Mar 2026 · 0 likes Post #149 describes the usual case. This is about the unusual one. Counterpoint on interpreting a result, offered without confidence: the same observation is consistent…
-
Measurement error in home scales, with a worked standard deviation Replied, post #17 · Research Methods › Statistics · 3 Mar 2026 · 12 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. Posting my measurement error in home scales numbers with the…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #70 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes Post #69 is right about the mechanism and I think understates the practical bit. Escalating before steady state means you are judging a dose you have not yet fully…
-
About the Regulatory category Replied, post #3 · Sourcing › Regulatory · 18 Feb 2026 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Managing an unplanned gap in supply Replied, post #26 · Access › Shortages · 8 Feb 2026 · 6 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. Reports that a pharmacy has stock are the least durable information on the site and…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #28 · Analytics › Mass spectrometry · 5 Feb 2026 · 5 likes Coming back to post #26, because the follow-up matters more than the original answer. Resolution: "high resolution" commonly means If the premise is wrong, everything…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #64 · Sourcing › Vendor reports · 1 Feb 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #60 · Clinical › Bloodwork · 25 Jan 2026 · 0 likes The honest answer on panel is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most people…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #12 · Compounds › Semaglutide · 23 Jan 2026 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #42 · Analytics › Method validation · 21 Jan 2026 · 0 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
-
Journal club: LEADER as the historical anchor Replied, post #23 · Evidence › Journal club · 15 Jan 2026 · 16 likes Nothing to add, except that this is the answer I would give if asked.
-
Revisiting: Absolute versus relative contraindications Replied, post #6 · Safety › Contraindications · 10 Jan 2026 · 4 likes Interaction-based contraindications are compound-pair specific and are the ones most often generalised incorrectly.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #14 · Practice › Storage & stability · 8 Jan 2026 · 23 likes Post #11 is the version of this I will quote in future. One addition. One caution on Adsorptive losses: everything above assumes the underlying documentation is what it…
-
The headache that turns out to be dehydration Replied, post #105 · Nutrition & Training › Hydration & electrolytes · 22 Dec 2025 · 0 likes Where there is a genuine question, a measurement answers it and a supplement does not. Blood tests for the common electrolytes are routine and cheap. I have written…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #99 · Compounds › Oral incretins · 19 Dec 2025 · 30 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #25 · Compounds › Retatrutide · 15 Dec 2025 · 2 likes The phase 2 obesity data is genuinely striking and it is phase 2 data. Sample sizes at that stage characterise a dose-response relationship; they do not characterise a…
-
Temperature loggers worth the money — the long version Replied, post #91 · Devices › Cold chain · 11 Dec 2025 · 19 likes I would be cautious about generalising from the Temperature loggers worth the money example above. It is a good example. It is one example.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #105 · Sourcing › Vendor reports · 6 Dec 2025 · 0 likes On post #103 — agreed on the reasoning, with one qualification. Where you have no independent result, a documentation report is still worth filing: what the certificate…
-
Reading SURMOUNT-1 without the press release Replied, post #83 · Compounds › Tirzepatide · 29 Nov 2025 · 14 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Reading SURMOUNT-1 without the press release Replied, post #68 · Compounds › Tirzepatide · 16 Nov 2025 · 0 likes The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why that trial carries more weight than its size…
-
Insomnia at a dose step: reported experiences Replied, post #25 · Wellbeing › Sleep · 16 Nov 2025 · 0 likes Any objective measurement, even an imprecise one, beats a recollection when the question is whether something changed. Worth reading the earlier posts in this thread…
-
Managing an unplanned gap in supply — what changed since Replied, post #106 · Access › Shortages · 4 Nov 2025 · 12 likes The confident answers on Managing an unplanned gap and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Tracking that stops updating and then resumes Replied, post #42 · Sourcing › Logistics · 3 Nov 2025 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. That is a description of practice, not a recommendation…
-
Airline travel with a temperature-sensitive injectable Replied, post #12 · Devices › Cold chain · 3 Nov 2025 · 11 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
Request: a diff view for wiki revisions — the long version Replied, post #64 · Meta › Feature requests · 2 Nov 2025 · 10 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #11 · Outcomes › Body composition · 2 Nov 2025 · 0 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Availability by country, dated, with primary sources Replied, post #41 · Access › International · 31 Oct 2025 · 8 likes Adding the measurement that post #38 says would settle it. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #9 · Evidence › Trials · 25 Oct 2025 · 9 likes On non-inferiority margins the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #16 · Compounds › Tirzepatide · 25 Oct 2025 · 0 likes Post #15 answers the question as asked. The question underneath it is different. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
New subcategory: rationale and scope Replied, post #103 · Meta › Announcements · 24 Oct 2025 · 18 likes New subcategory came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Payment mechanics and the recovery options that do not exist Replied, post #44 · Sourcing › Payments · 20 Oct 2025 · 4 likes Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #36 · Safety › Adverse events · 19 Oct 2025 · 26 likes Adding the measurement that post #33 says would settle it. The published trial rates come from supervised populations on defined schedules and are not comparable to…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #3 · Clinical › Bloodwork · 17 Oct 2025 · 0 likes On reference intervals, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Measurement error in home scales, with a worked standard deviation — a second dataset Replied, post #2 · Research Methods › Statistics · 17 Oct 2025 · 31 likes Building on the opening post rather than restating it. Regression to the mean: if you select people with extreme values (very high or very low), their next measurement…
-
A 40-week log with the measurement method stated Replied, post #16 · Outcomes › Progress reports · 15 Oct 2025 · 31 likes Post #15 answers the question as asked. The question underneath it is different. My experience of 40-week log contradicts the reply above. I am posting it as a data…
-
Availability by country, dated, with primary sources Replied, post #16 · Access › International · 10 Oct 2025 · 3 likes Whatever the answer on availability turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #7 · Practice › Dosing & titration · 30 Sep 2025 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
A comparison of home results against a laboratory result on the same vial Replied, post #41 · Analytics › Home & field testing · 25 Sep 2025 · 0 likes Taking post #40 at face value and following it one step further. Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96…
-
Personal import allowances, compared — a second dataset Replied, post #3 · Access › International · 24 Sep 2025 · 21 likes An update on my earlier Personal import allowances post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #61 · Sourcing › Vendor reports · 23 Sep 2025 · 1 like Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. I would want the raw data before agreeing…
-
Research-use-only labelling: what it means and what it does not Replied, post #36 · Sourcing › Regulatory · 21 Sep 2025 · 12 likes Thank you for the correction. I would rather find out here than later.
-
Titles that describe the question, not the situation — what changed since Replied, post #23 · Start Here › How to Ask · 17 Sep 2025 · 14 likes Titles: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Cross-border purchase rules within the EU Replied, post #11 · Regional › European Union · 13 Sep 2025 · 15 likes A device-and-compound combination has one authorisation and two supply chains, and the device is more often the limiting one. I am reporting what happened, not…
-
About the Mental health category Replied, post #4 · Wellbeing › Mental health · 10 Sep 2025 · 1 like Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #11 · Sourcing › Vendor reports · 30 Aug 2025 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #46 · Practice › Dosing & titration · 28 Aug 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #37 · Practice › Storage & stability · 27 Aug 2025 · 15 likes Reading back through the Freeze-thaw threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #17 · Wellbeing › Mental health · 11 Aug 2025 · 1 like Worth separating two things that post #13 runs together. The published trials collected mood data and the interpretation is contested. Being precise about what was…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #39 · Practice › Reconstitution · 9 Aug 2025 · 20 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I am not the…
-
A ten-fold dose error caught before injection — one year on Replied, post #158 · Devices › Syringes & needles · 5 Aug 2025 · 1 like Silicone coating on the barrel affects how smoothly the plunger moves and how a very slow injection feels. It is one reason two syringes at the same specification are…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #35 · Compounds › Secretagogues & GH axis · 4 Aug 2025 · 10 likes Understood, and I withdraw the assumption I opened with.
-
Asking about a compound your prescriber has not heard of Replied, post #110 · Clinical › Prescriber conversations · 30 Jul 2025 · 8 likes Where I part company with post #106, and it is a narrow parting. A question phrased as "what would you want to see before considering X" is answerable and is not a…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #75 · Compounds › Semaglutide · 18 Jul 2025 · 0 likes Post #72 is right about the mechanism and I think understates the practical bit. Adding a null result on Semaglutide half-life. I looked, carefully, and found nothing,…
-
Comparing my trajectory with the trial curves, carefully Replied, post #22 · Outcomes › Progress reports · 9 Jul 2025 · 3 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
What a 2 ppm match establishes, and what it does not Replied, post #30 · Analytics › Mass spectrometry · 2 Jul 2025 · 4 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #4 · Practice › Dosing & titration · 23 Jun 2025 · 1 like I had written a reply contradicting the opening post and deleted it. Here is what survived. Writing down the date, the dose and the site each week takes fifteen seconds…
-
Pre-registering a personal experiment, seriously Replied, post #104 · Research Methods › N-of-1 designs · 3 Jun 2025 · 1 like Coming back to post #100, because the follow-up matters more than the original answer. Committing to post the result before you know it is a useful precommitment, and…
-
Pre-registering a personal experiment, seriously Replied, post #68 · Research Methods › N-of-1 designs · 31 May 2025 · 20 likes Adding thanks rather than a view. I do not have a view worth the space.
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #10 · Wellbeing › Mental health · 28 May 2025 · 9 likes Coming back to post #6, because the follow-up matters more than the original answer. When to involve a professional: if mood changes are persistent, deepen over weeks,…
-
About the Datasets category Replied, post #7 · Data & Tools › Datasets · 23 May 2025 · 15 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #105 · Sourcing › Independent verification · 16 May 2025 · 18 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #38 · Evidence › Journal club · 12 May 2025 · 0 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. My position on STEP 4 is current rather than settled. I have revised it once…
-
Pages past their review date, listed — does this still hold? Replied, post #28 · Meta › Wiki maintenance · 11 May 2025 · 5 likes Housekeeping: three documents now carry the same paragraph verbatim because it was copied rather than linked. One of them should hold it and the other two should point…
-
Asking about a compound your prescriber has not heard of Replied, post #32 · Clinical › Prescriber conversations · 5 May 2025 · 3 likes Noted, and I have changed what I was going to do on the strength of it.
-
Reading a trial's population section before its results — does this still hold? Replied, post #33 · Evidence › Trials · 23 Apr 2025 · 33 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Checking someone else's arithmetic: a worked example thread Replied, post #39 · Practice › Reconstitution · 17 Apr 2025 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #22 · Practice › Reconstitution · 12 Mar 2025 · 27 likes Bookmarking this. I will come back when I have something worth adding.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #3 · Access › Insurance & coverage · 5 Mar 2025 · 32 likes I disagree with the framing of Coverage above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
Consistent declarations and why they matter more than clever ones Replied, post #100 · Sourcing › Logistics · 28 Feb 2025 · 26 likes Adding a null result on consistent declarations. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #66 · Evidence › Journal club · 23 Feb 2025 · 2 likes Whatever the answer on SURMOUNT-1 turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Telehealth prescribing models in the US Replied, post #55 · Regional › North America · 7 Feb 2025 · 12 likes This follows post #54 rather than contradicting it. For anyone finding this later: the short answer on telehealth prescribing models is that it depends on one thing,…
-
What changed in 2026, by region Replied, post #116 · Access › International · 2 Feb 2025 · 32 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #89 · Evidence › Journal club · 11 Jan 2025 · 2 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Coming back to: When to suspect the method rather than the sample Replied, post #115 · Analytics › Method validation · 22 Dec 2024 · 22 likes I read post #113 twice before replying, because I had assumed the opposite. A method that reports the same number for every lot is worth a second look. Real processes…
-
What changed in 2026, by region Replied, post #32 · Access › International · 21 Dec 2024 · 9 likes This follows post #30 rather than contradicting it. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #13 · Safety › Adverse events · 19 Dec 2024 · 0 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #33 · Analytics › Method validation · 6 Dec 2024 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. That distinction has done more work…
-
The retatrutide phase 2 obesity paper, read closely Started this topic · Compounds › Retatrutide · 26 Nov 2024 · 10 likes Posting this under the heading it deserves: The retatrutide phase 2 obesity paper, read closely Everything below is what sits behind that. Retatrutide phase 2 obesity…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #11 · Compounds › Oral incretins · 16 Nov 2024 · 33 likes Adding a data point of agreement rather than a data point.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #70 · Compounds › Repair & healing peptides · 16 Nov 2024 · 4 likes Post #66 describes the usual case. This is about the unusual one. If someone has run reading a preclinical wound-healing model properly I would rather read that than my…
-
Time to steady state after a dose increase Replied, post #125 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 1 like I read post #122 twice before replying, because I had assumed the opposite. Where two sources give different half-lives, check the study design before deciding either…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #20 · Meta › Wiki maintenance · 29 Oct 2024 · 25 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Question for the editors: what is the standard for adding a citation to a claim…
-
A page that has drifted out of date and needs a maintainer Replied, post #19 · Documentation › Wiki requests · 16 Oct 2024 · 27 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion. I looked this up rather than…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #3 · Evidence › Journal club · 14 Oct 2024 · 11 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #80 · Practice › Administration · 5 Oct 2024 · 16 likes I read post #78 twice before replying, because I had assumed the opposite. I disagree with the framing of site rotation scheme above, and I think it is a substantive…
-
Irish differences from the UK position Replied, post #18 · Regional › UK & Ireland · 2 Oct 2024 · 0 likes Where guidance distinguishes between indications, quoting the indication is essential. The same compound has different positions under different indications. I have…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #68 · Analytics › COA interpretation · 28 Sep 2024 · 0 likes Post #65 is right about the mechanism and I think understates the practical bit. What fields matter on a certificate: lot number matching the vial, test date, the…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Started this topic · Practice › Interactions · 10 Sep 2024 · 29 likes Anaesthesia and elective surgery: the aspiration question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #102 · Research Methods › Statistics · 24 Aug 2024 · 0 likes Agreed on correlation, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #24 · Analytics › COA interpretation · 10 Aug 2024 · 1 like What I would tell a new member reading about field-by-field walk through a certificate for the first time: the confident posts are not the reliable ones, and the…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #54 · Evidence › Journal club · 22 Jul 2024 · 8 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Journal club: FLOW and the renal composite, component by component Replied, post #33 · Evidence › Journal club · 12 Jul 2024 · 18 likes Coming back to post #30, because the follow-up matters more than the original answer. Where the group cannot agree, record the disagreement rather than resolving it by…
-
The mass-error checker and its intended scope Replied, post #9 · Data & Tools › Calculators · 23 May 2024 · 32 likes I would be cautious about generalising from the mass-error checker example above. It is a good example. It is one example.